The healthcare industry is undergoing a major transformation thanks to the advances in artificial intelligence (AI) and Generative AI in Digital Health. These technologies have the power to create new possibilities for drug discovery, diagnosis, treatment, and prevention of diseases. They can also enhance the quality, efficiency, and accessibility of healthcare services.
But how much do we really know about AI and Generative AI in healthcare? How can we separate the facts from the fiction, and the opportunities from the risks? How are Digital Health innovators leveraging Artificial Intelligence and Generative AI? Which healthcare industry verticals are experimenting with Digital Health ventures using Generative AI? How can we ensure that these technologies are used in a way that respects the values, rights, and interests of patients, healthcare professionals, and society at large?
This first-of-a-kind report by the Galen Growth Research team explores how Artificial Intelligence and Generative AI is being applied by Digital Health ventures to showcase the possibilities and challenges of the technology. Generative AI in Digital Health is still in its infancy and faces many obstacles before it can become a useful tool for the Digital Health industry, but this report highlights some of the ventures that are at the forefront of this innovation.
This Global Digital Health Innovation Thematic Report includes data on the following companies:
Atomwise, Athelas, Insilico Medicine, Huma, Hint Health, Neumora Therapeutics, HeartFlow, Monogram Health, Aledade, Gympass, Quris, Precision Scientific, Alentis Therapeutics, Strive Health, Viome Life Sciences, Rome Therapeutics, Hippocratic AI, Spring Health, MindMaze, BrainScope, Perceiv AI, Fathom, Mirvie, MediPixel, Suki, Navina, Medivis, IgniteData, Sonde Health, Vida Diagnostics, AIM Medical Service, Biorelate, Nova, Tempus, Nye Health, PicnicHealth, Anumana, Medii, Woebot Health, Virgin Pulse, Ginger.io, PathAI, Evio, Hinge Health, Cedar, Sensely, Roche, AstraZeneca, Novartis, Pfizer, Bayer, Mayo Clinic, NHS, Mass General Brigham, Mount Sinai Health System, Memorial Sloan Kettering, Cigna, Humana, AXA, Elevance Health, Kaiser Permanente, OpenAI, Google, Microsoft, Amazon
Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.
Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com to learn more about our data or https://www.galengrowth.com research for our reports.
Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com
|ABOUT GALEN GROWTH|
|INTRODUCTION: 8 pages, 7 charts|
|ECOSYSTEM INSIGHTS: 4 pages, 7 charts|
|CLUSTER FOCUS: 5 pages, 3 charts, 1 table|
|THERAPEUTIC FOCUS: 3 pages, 2 charts, 1 table|
|INVESTMENT INSIGHTS: 4 pages, 5 charts, 2 tables|
|DEEP DIVES: 22 pages, 17 charts, 3 tables|
|NOTEWORTHY: 3 pages, 4 tables|
© Galen Growth 2023